Accolade Investor Presentation Deck

Strong visibility to growth and profitability Targeting $1 billion revenue and 15-20% Adjusted EBITDA in FY29 29 Revenue AEBITDA $363M FY23 (10%) Horizon 1 $413M FY24P (~2%) ~$500M 2-4% FY25P Horizon 2 20% CAGR FY26-28P $1B+ 15-20% FY29P ● Key drivers Integrated healthcare platform o Advocacy o Primary Care and mental health o Expert Medical Opinion o Trusted Partner Ecosystem Continued market growth, penetration and leadership Increasing revenue-per-customer and net dollar retention Data-driven models achieve scale: Engineered to Care Scale drives margin expansion

View entire presentation